Magellan Health Stock Price and Value Analysis

Should you buy Magellan Health stock? (NasdaqGS:MGLN). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company has stable growth.
  • This stock looks overpriced.
  • This company is not making money.
  • This company pays no dividend.

MGLN Free Cash Flow Trend

Hmm, we can't give any reliable projection for Magellan Health's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for MGLN
Free Cash Flow trendline for Magellan Health

Inside the MGLN Numbers

MGLN Price
(Magellan Health stock price per share)
[?] PE Ratio versus Sector 27% higher than other Healthcare stocks
[?] PE Ratio versus Industry 118% higher than other Health Care Plans stocks
[?] Cash Yield 11.84%
[?] Free Cash Flow Jitter 24%

Is Magellan Health Stock on Sale?

Based on our analysis, we believe that you should not buy Magellan Health right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MGLN Stock?

Does Magellan Health have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.